KC
Karan Chopra
About Karan Chopra
Data last updated:
Karan Chopra is a Director at Lifecare Neuro Products Limited (since 2015) and Director at Pharmasource D2r Private Limited (since 2024). The companies operate in Chemicals. The largest current company by reported revenue is Lifecare Neuro Products Limited at ₹91.88 Cr (FY 2024).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Director | 01 Feb 2015 | 2004 | ₹91.88 Cr (FY 2024) | Active | |
| Director | 30 May 2024 | 2024 | Active |
Board colleagues of Karan Chopra
| Name | DIN | Company | Designation |
|---|---|---|---|
| Madhav Chopra | 06622336 | Lifecare Neuro Products Limited , Pharmasource D2r Private Limited | Director |
| Ravi Somdutt Chopra | 03546579 | Lifecare Neuro Products Limited | Director |
| Yogendra Chopra | 01996035 | Lifecare Neuro Products Limited , Pharmasource D2r Private Limited | Director |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Karan Chopra
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Karan Chopra
Karan Chopra currently holds 2 directorships: Lifecare Neuro Products Limited (Director, since 01 Feb 2015, revenue ₹91.88 Cr (FY 2024)); Pharmasource D2r Private Limited (Director, since 30 May 2024).
Karan Chopra was first appointed on 01 Feb 2015 as Director at Lifecare Neuro Products Limited. The most recent appointment on record is 30 May 2024 at Pharmasource D2r Private Limited.
The current boards of Karan Chopra's companies include Madhav Chopra (Lifecare Neuro Products Limited), Ravi Somdutt Chopra (Lifecare Neuro Products Limited), Yogendra Chopra (Lifecare Neuro Products Limited).